Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder

NCT00150605 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Extended-release carbamazepine

Sponsor

Validus Pharmaceuticals